| Primary |
| Product Used For Unknown Indication |
20.0% |
| Overdose |
9.5% |
| Symphysiolysis |
8.6% |
| Pyrexia |
8.3% |
| Intentional Overdose |
8.0% |
| Pain |
6.5% |
| Nasopharyngitis |
5.8% |
| Schizophrenia |
5.5% |
| Drug Use For Unknown Indication |
4.0% |
| Suicide Attempt |
4.0% |
| Analgesic Therapy |
3.7% |
| Migraine |
2.5% |
| Arthralgia |
2.2% |
| Systemic Lupus Erythematosus |
2.2% |
| Drug Abuse |
1.8% |
| Abdominal Pain |
1.5% |
| Back Pain |
1.5% |
| Intentional Self-injury |
1.5% |
| Oropharyngeal Pain |
1.5% |
| Fibromyalgia |
1.2% |
|
| Overdose |
24.5% |
| Intentional Overdose |
13.0% |
| Vomiting |
9.5% |
| Toxicity To Various Agents |
5.0% |
| Suicide Attempt |
4.5% |
| Urticaria |
4.5% |
| Hypotension |
4.0% |
| Multiple Drug Overdose |
4.0% |
| Acute Hepatic Failure |
3.5% |
| Abdominal Pain |
3.0% |
| Liver Injury |
3.0% |
| Nausea |
3.0% |
| Stevens-johnson Syndrome |
3.0% |
| Anaphylactic Reaction |
2.5% |
| Liver Disorder |
2.5% |
| Toxic Epidermal Necrolysis |
2.5% |
| Aspartate Aminotransferase Increased |
2.0% |
| Hepatitis Acute |
2.0% |
| Incorrect Dose Administered |
2.0% |
| Myalgia |
2.0% |
|
| Secondary |
| Pain |
27.8% |
| Product Used For Unknown Indication |
18.6% |
| Completed Suicide |
8.2% |
| Back Pain |
4.1% |
| Hypertension |
4.1% |
| Tooth Extraction |
4.1% |
| Analgesic Therapy |
3.1% |
| Depression |
3.1% |
| Drug Use For Unknown Indication |
3.1% |
| Surgery |
3.1% |
| Dissociative Identity Disorder |
2.1% |
| Epilepsy |
2.1% |
| Headache |
2.1% |
| Malaise |
2.1% |
| Migraine |
2.1% |
| Patent Ductus Arteriosus |
2.1% |
| Personality Disorder |
2.1% |
| Postoperative Analgesia |
2.1% |
| Respiratory Tract Infection |
2.1% |
| Schizophrenia |
2.1% |
|
| Vomiting |
13.5% |
| Suicide Attempt |
10.8% |
| Drug Toxicity |
8.1% |
| Toxicity To Various Agents |
8.1% |
| Alanine Aminotransferase Increased |
5.4% |
| Hepatitis Toxic |
5.4% |
| Overdose |
5.4% |
| Pneumonia |
5.4% |
| Pulmonary Embolism |
5.4% |
| Venoocclusive Disease |
5.4% |
| Acute Generalised Exanthematous Pustulosis |
2.7% |
| Anorexia Nervosa |
2.7% |
| Blood Creatine Phosphokinase Increased |
2.7% |
| Cerebrovascular Accident |
2.7% |
| Complex Partial Seizures |
2.7% |
| Dyspnoea |
2.7% |
| Hepatic Failure |
2.7% |
| Hypophagia |
2.7% |
| International Normalised Ratio Increased |
2.7% |
| Migraine |
2.7% |
|
| Concomitant |
| Constipation |
20.0% |
| Pain |
20.0% |
| Dementia |
13.3% |
| Aplastic Anaemia |
10.0% |
| Sleep Disorder |
10.0% |
| Convulsion |
6.7% |
| Nausea |
6.7% |
| Agitation |
3.3% |
| Aspergillosis |
3.3% |
| Confusional State |
3.3% |
| Dementia Alzheimer's Type |
3.3% |
|
| Type 2 Diabetes Mellitus |
42.9% |
| Stevens-johnson Syndrome |
28.6% |
| Protein Total Abnormal |
14.3% |
| Urinary Tract Infection |
14.3% |
|
